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https://doi.org/10.1002/nbm.4105Arterial spin labeling (ASL)‐MRI can noninvasively map cerebral blood flow (CBF) and
cerebrovascular reactivity (CVR), potential biomarkers of cognitive impairment and
dementia. Mouse models of disease are frequently used in translational MRI studies,
which are commonly performed under anesthesia. Understanding the influence of the
specific anesthesia protocol used on the measured parameters is important for accu-
rate interpretation of hemodynamic studies with mice. Isoflurane is a frequently used
anesthetic with vasodilative properties. Here, the influence of three distinct
isoflurane protocols was studied with pseudo‐continuous ASL in two different mouse
strains. The first protocol was a free‐breathing set‐up with medium concentrations,
the second a free‐breathing set‐up with low induction and maintenance concentra-
tions, and the third a set‐up with medium concentrations and mechanical ventilation.
A protocol with the vasoconstrictive anesthetic medetomidine was used as a compar-
ison. As expected, medium isoflurane anesthesia resulted in significantly higher CBF
and lower CVR values than medetomidine (median whole‐brain CBF of 157.7 vs
84.4 mL/100 g/min and CVR of 0.54 vs 51.7% in C57BL/6 J mice). The other two
isoflurane protocols lowered the CBF and increased the CVR values compared with
medium isoflurane anesthesia, without obvious differences between them (median
whole‐brain CBF of 138.9 vs 131.7 mL/100 g/min and CVR of 10.0 vs 9.6%, in
C57BL/6 J mice). Furthermore, CVR was shown to be dependent on baseline CBF,
regardless of the anesthesia protocol used.
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2 of 12 MUNTING ET AL.1 | INTRODUCTION
Cerebral blood flow (CBF) and cerebrovascular reactivity (CVR) are emerging as potential biomarkers for cognitive impairment and dementia.1,2
They can be measured in the clinic3 and in preclinical research4,5 by means of MRI‐based perfusion imaging. The arterial spin labeling (ASL)
MRI technique is particularly attractive as it is completely noninvasive, using blood water as an endogenous tracer. This enables repeated mea-
sures for dynamic recordings of responses to stimuli such as a “CO2 challenge” for assessment of CVR.
Mouse models are important tools for translational neuroscience and neurology. Although MRI studies with awake mice have been per-
formed,6,7 this approach is often tied to ethical and technical restrictions that heavily restrict practical application. Therefore, mouse MRI is com-
monly performed under anesthesia. However, anesthesia protocols are known to influence cerebral hemodynamics. In order to more clearly relate
MRI measures of brain hemodynamics obtained from mouse models to clinical data, and for meaningful comparison with other preclinical studies,
it is important to understand the hemodynamic influence of the different anesthesia protocols used. Furthermore, different mouse strains may
vary in their response to the anesthesia protocol used.8,9 It is therefore important to devise standardized protocols in order to provide comparable
and reproducible CBF and CVR estimates. Isoflurane is the most widely used anesthetic in imaging studies with mice, probably due to its very
straightforward method of administration, fast reversibility and the minimal long‐term side effects, even upon repeated use in the same animal.10
However, isoflurane also has a dose‐dependent vasodilatory effect,11 as well as a dose‐dependent respiratory depressive effect.12,13 Thus, it has
been posited to reduce the dynamic range in ASL‐based CVR studies, both directly via its vasodilatory effect and—if not ventilated—indirectly via
an increase in the partial pressure of arterial pCO2 as a consequence of respiratory depression.
Blood oxygen level dependent functional MRI (BOLD‐fMRI) studies also appear to be impaired by isoflurane in a dose‐dependent manner, as
stimulus‐evoked BOLD responses and resting state network organization have been shown to be reduced when higher levels of isoflurane were
used.14,15 In order to benefit from its otherwise favorable characteristics, refinements have been proposed to minimize the needed dose of
isoflurane. For example, combining it with a low dose of medetomidine permits stable anesthesia at 0.5% of isoflurane.16 Also, isoflurane has been
combined with the paralysis agent pancuronium bromide to support mechanical ventilation, with maintenance levels of 1.0%.17 However, combi-
nation with paralyzing agents or medetomidine may not always be wanted, due to ethical reasons or unresponsiveness of the mouse strain used,
respectively.9 Alternatively, Wells et al showed that by simply administrating a relatively low concentration of isoflurane both during induction
(2.0%) and maintenance (1.5%)—without any other anesthetic—workable CVR values can be obtained in an ASL‐based CVR study.18
In this work we provide the first comprehensive assessment of CBF and CVR in the mouse brain under different anesthetic regimes using
pseudo‐continuous ASL‐MRI in C57BL/6 J mice. In particular, given the prevalence and unique perks of isoflurane anesthesia, we compare three
distinct isoflurane‐based protocols: (i) a free‐breathing isoflurane protocol with doses that reflect commonly used isoflurane concentrations in
mouse brain MRI studies,9,19 defined henceforth as the “medium‐dose” protocol; (ii) the protocol described by Wells et al,18 where a relatively
low dose of isoflurane was used for both induction and maintenance, defined henceforth as the “low‐dose” protocol; and (iii) a medium‐dose
isoflurane protocol with mechanical ventilation to counteract the respiratory depressive effect. Additionally, we compare the three isoflurane pro-
tocols with a medetomidine anesthesia protocol, which is known to be vasoconstrictive. Furthermore, we evaluate the low‐dose and ventilated
isoflurane protocols in a second mouse strain, partly on a C3H/HeJ background, a strain with known respiratory anomalies.20
2 | EXPERIMENTAL
This study was performed in compliance with the guidelines of the European community for the care and use of laboratory animals (EUVD
86/609/EEC) and was reported conforming to the ARRIVE guidelines.21
2.1 | Animal procedures
All experiments were approved by the local ethics committee “Instantie voor Dierenwelzijn” of the Leiden University Medical Center and were
performed under DEC permits 11165 and 14073.
Thirty‐three wild‐type C57BL/6 J mice (31 males, two females) were used at 10.7 months (standard deviation [SD] 6.5 months), with a mean
weight of 35 g (SD 6 g). The second wild‐type strain used in this study was the F2 generation of a cross of C57BL/6 J and C3H/HeJ mice, referred
to henceforth as B6C3. Eleven B6C3 mice (seven males, four females) were used at 13.5 months (SD 0.5 months), with a mean weight of 46 g (SD
7 g). The mice were derived from an in‐house breeding. Founder mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). The
mice were co‐housed in individually ventilated cages (2–4 per cage) in a 12 h dark/light cycle‐ML2‐facility. They had unlimited chow food and
water at their disposal and were supplied with bedding material and cage enrichment.
2.2 | Anesthesia and monitoring of the physiological signals
The following four anesthesia protocols were used (dose, route of administration, animal number and age per group are summarized in Table S1):
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during maintenance the breathing rate was kept between 80 and 100 bpm by adjusting the isoflurane accordingly between 1.5–2.0%. The
isoflurane was administered in medical air enriched with oxygen (air:oxygen 3:1). This protocol is referred to as the medium‐dose isoflurane
protocol.
2. An isoflurane protocol with 2.0% induction for five minutes and 1.25% maintenance, based on the protocol described in Wells et al.18 How-
ever, to restrict the accumulation of isoflurane even more, the maintenance concentration was lowered to 1.25% (instead of 1.50% in Wells
et al), which was the minimum in our study. Some B6C3 animals required slightly longer induction times to be sufficiently anesthetized. For
both strains, a quick transfer from the induction box to the animal bed of the MRI set‐up was necessary to prevent awakening. The isoflurane
was administered in pure medical air, in accordance with Wells et al.18 This protocol is referred to as the low‐dose isoflurane protocol.
3. An isoflurane protocol with 3.5% induction for four minutes, 1.75% maintenance and intubation and mechanical ventilation. After induction,
the mouse was taken out of the induction box and transferred to a supine position and supplied with a nose cone with continued 3.5%
isoflurane administration. The trachea was subsequently endotracheally intubated, after which the mouse was transferred to the scanner
bed and the isoflurane was then decreased to 1.75%. There, the mechanical ventilation was started with a CWE MRI‐1 ventilator (Ardmore,
OK, USA) with settings as recommended during the Functional MRI in Mice workshop in November 2016 at the animal imaging center of
the ETH Zürich, Switzerland: a rate of 80 bpm, a tidal volume of 1.7 mL, and inspiration of 25%. The animal was not paralyzed during the scan.
Both the gas used during induction and the air used during ventilation consisted of oxygen‐enriched medical air (air:oxygen 3:1). This protocol
is referred to as the medium‐dose isoflurane + ventilation protocol.
4. A medetomidine protocol. Here, anaesthesia was also induced with 3.5% isoflurane in oxygen‐enriched medical air (air:oxygen 3:1) for four
minutes. After transfer to the animal bed, the isoflurane was decreased to 2.0%, and after finalizing the set‐up, a subcutaneous catheter
was inserted into the flank of the animal. Then a 0.15 mg/kg bolus of dexmedetomidine hydrochloride was given (Dexdomitor, Vetoquinol
SA, Lure, France [a solution without levomedetomidine]), followed 10 minutes later by 0.30 mg/kg/h infusion with a syringe pump (Univentor
802, Univentor High Precision Instruments, Zejtun, Malta). Note that this is equivalent to a 0.30 mg/kg bolus and 0.60 mg/kg/h infusion pro-
tocol when a mixture of both active (dexmedetomidine) and inactive (levomedetomidine) enantiomers is used. During the 10 minutes between
bolus and infusion, the isoflurane was decreased to 0%, but the administration of oxygen‐enriched air was continued. The protocol is based on
the optimal findings in the medetomidine optimization study by Adamczak et al.22 This protocol is referred to as the medetomidine protocol.
For physiological monitoring, heart and respiration rates were captured with a pressure‐sensitive pad below the animal and a pulse oxygena-
tion probe around the hind paw, respectively (SA Instruments, New York, NY, USA). Temperature was maintained around 36.5°C with a water bed
plugged into a feedback control system (Medres, Cologne, Germany). Furthermore, a transcutaneous probe (Radiometer, Zoetermeer, the
Netherlands) was applied on the shaved flank of the mouse for noninvasive collection of the transcutaneous partial pressure in carbon dioxide
(tc‐pCO2). As absolute arterial pCO2 values are not reflected by the tc‐pCO2 values, whereas changes in arterial pCO2 are reflected by changes
in tc‐pCO2,
23 the tc‐pCO2 plots are shown as absolute change of tc‐pCO2 in mmHg during challenge relative to baseline. Due to a technical error
during the medetomidine scans, seven out of the 11 tc‐pCO2 profiles were not captured in this group. For each anesthesia protocol, representa-
tive CBF, heart rate, respiration rate and tc‐pCO2 time‐profiles are shown in Figure S1. In a few animals, parts of the heart or respiration rate time‐
profiles were not captured properly, as illustrated in Figure S1. Such incorrectly sampled data were excluded from the median and interquartile
range (iqr) calculation of the heart and respiration rates, which is shown in Table S2.2.3 | MRI measurements
A 7 T Pharmascan (Bruker Biospin GmbH, Ettlingen, Germany) was used with a 23 mm volume resonator.
2.3.1 | Anatomical scans
For planning of the pCASL sequence, anatomical T2‐weighted magnitude images were acquired with a RARE sequence in the axial, sagittal and
coronal orientation, using the following parameters: TE/TR/flip angle (FA) = 35.0 ms/2500 ms/90 degrees, matrix 256 x 256, FOV 21.55 x
21.55 mm, 0.7 mm slice thickness, no slice gap, 1 average, RARE factor of 8, and a bandwidth of 36.7 kHz. Additionally, a set of anatomical images
with the same geometry as the pCASL read‐out was acquired for registration purposes.
2.3.2 | Cerebral blood flow measurements
A pCASL sequence enabled measurement of the cerebral blood flow. The pCASL‐interpulse phases were optimized to correct for off‐resonance
effects with prescans.24 Labeling pulses were applied with 3.5 μT B1, 400/800 μs pulse duration/interval, and a total labeling duration (τ) of
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out parameters were used: TE/FA = 16.8 ms/90 degrees, four dummy scans, matrix size 96 x 96, FOV 21.55 x 21.55 x 1.5 mm, three slices with
the middle slice position at −0.75 mm Bregma and at the isocenter of the bore and a maximum/average labeling gradient of 45.0/5.0 mT/m. The
labeling slice was always positioned exactly 1.0 cm from the middle imaging slice, which is around 4 mm upstream of the split of the common
carotid artery. The TR was 3520 ms, meaning that each control/labeled pair of images took 7.04 seconds to acquire. An example of the planning
and the resulting ASL images is shown in Figure S2.
To support CBF‐quantification, tissueT1 (T1 t) maps were acquired with an inversion recovery EPI sequence with 18 inversion times, and label-
ing efficiency (α) was measured in the carotids 3 mm downstream of the labeling plane with a flow‐compensated, ASL‐encoded FLASH sequence.
2.3.3 | Timeline of the CBF measurements
CBF time‐profiles were acquired for 21 minutes separated in three fragments of seven minutes: seven minutes baseline, seven minutes 7.5% CO2
challenge, seven minutes back to baseline. This duration was chosen to collect 60 repetitions for each fragment of the sequence, thus with a total
of 180 repetitions. During the challenge, the oxygen concentration stayed the same, ie 7.5% CO2 replaced N2 in the air mixture.
2.4 | Image processing
2.4.1 | Alignment of the pCASL and inversion recovery EPIs
A MATLAB monomodal rigid‐body registration (300 iterations) was applied on the label and control magnitude images collected by the pCASL
sequence to align them to the first label magnitude image of the sequence. In the same way, the 18 inversion recovery EPIs were aligned to
the first label magnitude image of the pCASL sequence. The CBF and T1 t maps could then be computed voxel‐wise.
2.4.2 | Cerebral blood flow quantification
The CBF was quantified in mL/100 g/min using Buxton's general kinetic perfusion model.25 Assuming that M0b, the magnetization of arterial
blood at thermal equilibrium, may be approximated by M0 t/λ, where M0 t is the magnetization of tissue and λ is the blood–brain partition coef-
ficient of water, ie 0.9 mL/g,26 the following equation was used:
CBF ¼ λ·ΔM·exp PLD=T1bð Þ
2·α·T1t·M0t· 1 − exp −τ=T1tð Þð Þ (1)
where ΔM is the measured difference between label and control acquisition and T1b is 2230 ms, the longitudinal relaxation time of blood at 7 T.27
2.4.3 | Delineation of the brain regions
The anatomical T2‐weighted magnitude images in one dataset of the study served as the basis for the delineation of the full brain and the cortex.
These brain regions were then automatically propagated to the anatomical T2‐weighted magnitude images of the other datasets by applying a
monomodal optical‐flow registration algorithm. The field of transport V
!
was thus estimated on a pixel‐by‐pixel basis by means of the following
minimization process:
argmin
V
! ∫Ω It þ V
!
·∇
!
I
 þ α ∇!u 2
2
þ ∇!v
 2
2
 
d r! (2)
where Ω ⊆ R2 is the image coordinate domain, It the temporal partial derivative of the image intensity I calculated between the time points t and
t + δt, (u,v) the estimated components of transport vectors, and r! ∈ Ω the spatial location. The minimized functional accounts for the two follow-
ing additive contributions: (i) a data fidelity term (left part of the integral in Equation (2)) that measures, through a L1L1 norm, the similarity
between the images, and (ii) a regularization term (right part of the integral in Equation (2)) designed to provide a sufficient conditioning to the
numerical scheme. The regularization term is given by ∇
!
u
 2
2
¼ u2x þ u2y and ∇
!
v
 2
2
¼ v2x þ v2y , uxux, uuyy, vxvx and vvxy being the spatial partial
derivatives of u and v, respectively. The regularization term alpha was set to 0.5. The results of this propagation step were then verified
dataset‐by‐dataset by an operator (L.P. Munting).
In each dataset, the in‐plane spatial transformation between the anatomical T2‐weighted magnitude image and the first frame of the pCASL
magnitude image (ie the reference image chosen previously) was then automatically estimated as follows: an edge‐based variational method for
nonrigid multimodal registration28 was employed to circumvent potential geometrical distortions induced by the EPI readout. For this purpose,
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edges/gradients that are present in both images, as described in Chen et al.29 The obtained motion‐vector field was subsequently employed to
adjust the position of the masks of each brain region. Here again the results of this propagation step were verified dataset‐by‐dataset by an oper-
ator (L.P. Munting).
2.4.4 | CVR quantification
The spatial mean of the CBF in each brain region was collected frame‐by‐frame, which enabled quantification of the CVR by computing the fol-
lowing estimates: (i) baseline CBF from the mean CBF of the 20 repetitions, ie two minutes 20 seconds, before the onset of the CO2 challenge, and
(ii) CBF during CO2 challenge based on the 20 repetitions before the end of the CO2 challenge. The percentage of CVR was calculated by applying
the following equation:
CVR %ð Þ ¼ 100* mean CBF during challenge
mean baseline CBF
− 1
 
(3)
2.5 | Statistical analysis
Estimates are expressed as median (iqr), except for the time‐profiles in the figures, which are given in mean (standard deviation [SD]) to better
visualize the group response. The statistical tests were performed using IBM SPSS statistics software package version 23 (Armonk, New York,
NY, USA). For multiple comparisons, initially a Kruskal‐Wallis test was used to evaluate whether the nonparametric unpaired groups belonged
to the same distribution. If a significant difference was found, post hoc testing was performed with Dunn‐Bonferroni tests to assess which groups
differed. Mann–Whitney tests were only used when comparing two groups.3 | RESULTS
3.1 | Comparison of the anesthesia protocols in C57BL/6 J mice
The CBF time‐profiles for the different anesthesia protocols are displayed in Figure 1A,B for full‐brain ROIs and cortical ROIs, respectively. CBF
and CVR maps of individual mice representative of their groups and their respective anatomical T2‐weighted images are shown in Figure 1C. The
lowest baseline CBF estimates were found using the medetomidine protocol, and the highest when administering medium isoflurane. The other
two isoflurane protocols are in‐between, without an obvious difference between the two. Figure 2A,B shows CBF time‐profiles normalized to
the baseline CBF values for the full brain and cortex, respectively. The resulting CVR values are compared in Figure 2C,D with boxplots for full
brain and cortex, respectively. Here, an opposite trend is observed for the anesthesia protocols, with medium isoflurane resulting in the lowest
CVR, and medetomidine resulting in the highest CVR. Again, the other two isoflurane protocols result in an intermediary CVR response, with sim-
ilar results recorded.
The distribution of CBF and CVR values in both full brain and cortex for the four anesthesia protocols were significantly different from each
other (H (3) = 19.02 and P < 0.001; H (3) = 24.24 and P < 0.001; H (3) = 12.36 and P = 0.006; H (3) = 14.75 and P = 0.002 for full‐brain CBF, full‐
brain CVR, cortical CBF and cortical CVR, respectively). Post hoc analysis indicated that the CBF values in the full brain obtained under
medetomidine (84.4 mL/100 g/min [31.4 mL/100 g/min]) were significantly lower than those obtained with medium isoflurane
(157.7 mL/100 g/min [41.72 mL/100 g/min]) and significantly lower than those obtained under low isoflurane (138.9 mL/100 g/min
[26.5 mL/100 g/min]), adjusted P = 0.001 and adjusted P = 0.006, respectively. Regarding the CVR values in the full brain, the same groups dif-
fered: medium isoflurane (0.5% [3.1%]) vs medetomidine (51.7% [25.7%]), adjusted P < 0.001; low isoflurane (10% [7.1%]) vs medetomidine,
adjusted P = 0.036. Most of the other comparisons lost their statistical significance after Dunn‐Bonferoni correction. For the low isoflurane
and medium isoflurane + ventilation CBF and CVR comparisons, however, even uncorrected P‐values were not significant (0.688 and 0.974,
respectively), reflecting their similar CBF time‐profiles. In the cortical ROIs, statistical testing gave comparable results as in the full‐brain ROIs (data
not shown). Median and iqrs of the CBF and CVR values per anesthesia protocol are given in Table S3.
It should be pointed out that in the medetomidine group, not all of the individual baseline CBF profiles were stable yet, even though the
medetomidine infusion started 20 minutes before the pCASL scan (see Figure S4). It is also to be noted that, unlike the isoflurane anesthesia pro-
tocols where the CVR is most pronounced in the cortex, the CVR obtained using the medetomidine protocol was strongly present throughout the
full brain. Also observed in the CBF time‐profile of medetomidine only is a continuing CBF increase during hypercapnia, suggesting a competition
between processes (vasoconstrictive medetomidine and vasodilative CO2) influencing the CBF. This is reflected in the time to half peak (TTHP)
distributions, which were also different between the anesthesia protocols, H (3) = 9.701 and P = 0.021 in the full brain and H (3) = 9.105 and
FIGURE 1 Absolute CBF values and CBF maps for the four different anesthesia protocols in C57BL/6 J mice. Mean and standard deviation of the
absolute CBF profiles in (A) the full brain and in (B) the cortex. (C) Representative examples of images acquired at −0.75 mm from Bregma. In the
columns from left to right: Anatomical images with cortical ROIs; mean CBF maps collected in the last two minutes before the onset of the CO2
challenge; mean CBFmaps collected in the last two minutes during CO2 challenge; and CVRmaps. All the images on a row are from the same mouse
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adjusted P = 0.03.
There were no significant differences in the tc‐pCO2 rise upon CO2 challenge between the different anesthesia protocols (Figure S3, H (3) =
6.167; P = 0.104). The median heart rates were lower and respiration rates higher in the medetomidine group (Table S2), which was to be expected
given the known respiratory depressive action of isoflurane12,13 and the known bradycardic action of medetomidine.303.2 | Comparison of the anesthesia protocols in B6C3 vs C57BL/6 J mice
The B6C3 mice could not be sedated sufficiently with medetomidine, thus compromising the use of this anesthetic for this strain. The application
of the low isoflurane protocol in free‐breathing B6C3 mice showed a higher but nonsignificant mean baseline CBF in B6C3 mice compared with
C57BL/6 J mice (Figure 3; full brain: U = 21.0, Z = −1.405, P = 0.180; cortex: U = 24.0, Z = −1.124, P = 0.291). Using the low isoflurane protocol, a
significantly lower CVR in B6C3 mice was found vs C57BL/6 J mice: 3.1% (4.6%) vs 10.0% (7.1%) in the full brain (U = 4.0, Z = −2.997, P = 0.001);
and 4.5% (1.1%) vs 12.7% (9.3%) in the cortex (U = 7.0, Z = −2.716, P = 0.005) (Figure 3A‐D). Interestingly, the change in tc‐pCO2 was also
significantly lower in B6C3: mean rise of 18.6 mmHg in C57BL/6 J mice vs 11.5 mmHg in B6C3 mice (Mann–Whitney, P = 0.014) (Figure 3E).
FIGURE 2 CVR relative to the baseline CBF for the four different anesthesia protocols in C57BL/6 J mice. CVR estimates are computed in the
full brain (A, C, E) and in the cortex (B, D, F)
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4.7 mmHg only in C57BL/6 mice (normalized SD of 25%) (Figure 3E).
When using medium isoflurane + mechanical ventilation, the difference in CVR in B6C3 mice vs C57BL/6 J mice was abolished: 6.8% (12.1%)
vs 9.6% (15.1%) in the full brain (U = 8.0, Z = −0.940, P = 0.421), and 4.4% (17.5%) vs 12.2% (23.5%) in the cortex (U = 8.0, Z = −0.940, P = 0.421)
(Figure 4A‐D). With mechanical ventilation, both strains displayed a similar tc‐pCO2 rise, with a mean rise of 13.2 mmHg (7.3) vs 10.8 mmHg (6.8)
in B6C3 mice (t‐test, P = 0.595) (Figure 4E).3.3 | End of the hemodynamic capacity reserve with high baseline CBF values
To visualize the dependency of CVR on baseline CBF, a correlation plot between the two is shown in Figure 5. There is a strong negative corre-
lation between baseline CBF and CVR, with high baseline CBF values resulting in a blunted or absent CVR response regardless of the protocol
used, indicating the maximum of the hemodynamic capacity is reached. Only measurements in C57BL/6 J mice were used for this plot.
FIGURE 3 CBF and CVR values for the “low isoflurane” protocol in C57BL/6 J mice (blue) vs B6C3 mice (red). Time‐profiles of the CBF acquired
in (A) the full brain and in (B) the cortex. (C, D) the CVR is significantly different between both strains. (E) the transcutaneous pCO2 rise was
significantly different at the time of maximum pCO2 rise
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The current increase of studies investigating hemodynamics in the mouse brain requires a better understanding of the physiological influence of
the anesthesia protocols used. Our results demonstrate exquisite sensitivity of CBF and CVR to the anesthesia protocol employed, findings that
reinforce the need for care in the experimental design and interpretation of studies of murine cerebrovascular function, where anesthesia is often
required. Isoflurane is the most widely used anesthestic due to its many advantages, but it has the disadvantage of being a dose‐dependent vaso-
dilator and a respiratory depressant. In this study, we focused on the influence of different isoflurane protocols on the hemodynamic measures
CBF and CVR to a CO2 stimulus. A medium‐dose isoflurane protocol was compared with two alternative isoflurane protocols that have been
adapted to minimize its vasodilatory and/or respiratory depressive properties: a low‐dose isoflurane protocol and a medium‐dose isoflurane pro-
tocol with mechanical ventilation. To put the results in context, the isoflurane protocols were also compared with the vasoconstrictive
medetomidine protocol. All four protocols were tested in the commonly used C57BL/6 J mouse strain. Lastly, the performance of the adapted
isoflurane protocols were also assessed in a second mouse strain, namely, the mixed background B6C3 strain.
FIGURE 4 CBF and CVR for the “standard isoflurane + mechanical ventilation” protocol: C57BL/6 J mice (blue) vs B6C3 mice (red). Time‐profiles
of the CBF acquired in (A) the full brain and in (B) the cortex. CVR in (C) the full brain and in (D) the cortex, which are not significantly different in
B6C3 vs C57BL/6 J mice. (E) Tc‐pCO2 rise in B6C3 vs C57BL/6 J mice was not significantly different
MUNTING ET AL. 9 of 12As reported previously,9 the medium isoflurane protocol resulted in a high baseline CBF, thus blunting the CVR. Conversely, the medetomidine
protocol yielded the lowest CBF and highest CVR, with median CVR estimates over 50% in C57BL/6 J mice. As intended, the adapted isoflurane
protocols lowered basal CBF compared with the medium isoflurane protocol. Consequently, workable CVR values were obtained. There was no
observable difference between the two adapted isoflurane protocols. This is interesting, because with the low isoflurane protocol, both the
vasodilatory and the respiratory depressive effects are reduced compared with the medium isoflurane protocol, whereas with the medium
isoflurane + ventilation protocol, only the respiratory depressive effects are reduced. Thus, it implies that the respiratory depression plays a major
role in the outcome of the high baseline CBF with the medium isoflurane protocol. Because of its much easier implementation, we recommend
researchers unexperienced with intubation the low isoflurane protocol over the medium isoflurane + ventilation protocol for CVR studies with
perfusion imaging. It should be stressed here, that in our experience, not only the low maintenance, but also the low induction is of extreme impor-
tance for maintaining some hemodynamic reserve capacity. Compared with the other protocols, the low induction keeps the respiration rate
FIGURE 5 CVR expressed as a function of the baseline CBF in C57BL/6 J mice. Each dot represents one mouse, where the colour indicates the
anesthesia protocol used. Relations are given for (A) the full brain and (B) the cortex
10 of 12 MUNTING ET AL.higher, especially during the beginning of the anesthesia period, and fully avoids any spasmodic breathing. Also to be noted is that studies have
been reported with lower maintenance concentrations than our low isoflurane protocol.6,14 In our study we could not lower the isoflurane con-
centration, as the animals would then have woken up. Perhaps local differences in isoflurane delivery systems can explain differences in lower
boundaries of isoflurane maintenance. In Table S4, a list of advantages and disadvantages of the different anesthesia protocols in this study are
summarized.
A wider range of anesthetics has been used for rodent MRI studies than was used here. Most of these anesthetics have been reported to affect
hemodynamic regulation. For example, propofol reduces blood pressure and is respiratory depressive.31,32 Other fluorinated gases than isoflurane
such as halothane and sevoflurane have a similar hemodynamic influence as isoflurane.33 Of particular interest are urethane and etomidate. These
anesthetics are known to have very little effect on hemodynamics.9,34,35 However, urethane is not applicable to longitudinal studies, because of
the toxicity of the compound. Etomidate sedation has been suggested as a widely applicable anaesthesia regime in multiple strains.9,35 It is even
preferred for anesthesia induction of cardiac patients, because of its lack of hemodynamic influence.36 However, the current availability of formu-
lations of etomidate is very limited and, to the best of our knowledge, etomidate is only available in a concentration of 2 mg/mL. This means that
injection volumes needed for at least one hour of sedation exceed the animal welfare guidelines.37 A recent paper showed that it was possible to
measure unilateral BOLD responses upon a somatosensory stimulus repeatedly in the same mouse anesthesized with a novel ketamine/xylazine
formulation.38 It would therefore be of interest to characterize the absolute CBF and CVR profiles with this new ketamine/xylazine formulation.
Unfortunately, B6C3 mice exhibited an insufficient anesthetic depth with medetomidine, thus compromising the use of this anesthetic for this
strain. This insensitivity probably comes from the C3H strain. Medetomidine has been reported to show limited efficacy of anaesthesia, not only in
C3H mice, but also in BTRB T + tf/J mice and CD1 strains.9 Therefore, if medetomidine use is uncharacterized in a mouse strain, we recommend
careful bench studies with frequent monitoring of anesthetic depth and physiological measures such as heart and respiration rate before starting
an MRI experiment with medetomidine. Another limitation of medetomidine is the unstable baseline CBF that was sometimes observed in the
C57Bl/6 J mice. This is probably a result of the switch from isoflurane induction to medetomidine. The dynamics of CBF stabilization under
medetomidine are not well known and this could be an interesting subject for future research. However, because the sedation time of
medetomidine is limited (around one hour starting from the time of bolus injection),22 it would be risky to delay the start of the pCASL scan as
the animal may wake up before the end of the scan.
A different complication with the CVR measurements was encountered when using the low isoflurane protocol in free‐breathing B6C3 mice.
Here, a CBF response to CO2 was nearly absent (3.1% CVR). Interestingly, when comparing the mean tc‐pCO2 increase with the same hypercapnia
protocol in free‐breathing mice, B6C3 mice also had a significantly lower tc‐pCO2 increase compared with C57BL/6 J mice (11.5 mmHg vs
18.6 mmHg). When the B6C3 mice were mechanically ventilated, the differences in both CVR and tc‐pCO2 between B6C3 and C57BL/6 J mice
were abolished. It has been reported before that C3H mice have a low respiratory sensitivity to hypercapnic stimulation.20 However, it seems par-
adoxical that a lower tc‐pCO2 increase is measured in free‐breathing mice with a lower respiratory response to CO2, as a lower respiratory
response is expected to less efficiently remove CO2 from the body. Further research is therefore necessary to clarify if and how the reduced
CVR, reduced tc‐pCO2 rise, and low respiratory sensitivity to hypercapnia in the B6C3 mice anesthesized with low isoflurane are related.
Whole‐body plethysmography to measure minute ventilation as well as more reliable pCO2 measurements such as end‐tidal CO2 or blood sam-
pling could provide more insight to this matter. Also to be taken into account is that factors such as skin perfusion influence the diffusion of
CO2 through the skin,
23 which might in turn be influenced by the anesthesia protocol used. This may bias the tc‐pCO2 measurements, which is
why we chose not to express CVR per mmHg rise of transcutaneous CO2.
MUNTING ET AL. 11 of 12A few limitations specific to this study should be taken into account. The large age range of the animals and the different oxygen content in the
low isoflurane protocol (20% vs around 40% O2 in the other protocols) might have biased the results. However, this bias is probably small, as sev-
eral studies have shown that brain hemodynamic parameters are preserved with age in wild‐type mice,5,39,40 and because the effect of 100% O2
inhalation on the baseline CBF has been shown to be an order of magnitude lower than that of hypercapnia.41 Another limitation is that, because
of technical constraints, the labeling efficiency was only measured in the carotids, and not in the vertebral arteries. This might have introduced
noise in the CBF values of the flow territory of the vertebral arteries (the posterior part of the brain), but this is not expected to be different
between groups. Lastly, the absence of paralysis in the mechanically ventilated animals sometimes resulted in counter‐breathing, especially during
the CO2 administration, probably explaining the greater fluctuations in CBF time‐profiles in this group.
In conclusion, this study stresses the importance of careful selection of the specific anesthesia protocol for CBF and/or CVR studies in the
mouse brain. From the four protocols tested, the medetomidine protocol showed the lowest CBF and highest CVR values, as was expected given
medetomidine's vasoconstrictive properties. However, an important limitation is that medetomidine induces insufficient depth of anaesthesia in
several mouse strains. Despite the known vasodilative properties of isoflurane, CVR studies were possible with the two adapted isoflurane pro-
tocols, with comparable CVR values in C57BL/6 J mice. Of these two, the free‐breathing low isoflurane protocol may experimentally provide
the most straightforward protocol. With this protocol, it is important that the isoflurane dose is kept low during both induction and maintenance.
Furthermore, CVR was shown to be highly dependent on the baseline CBF, with high baseline CBF resulting in blunted CVR.
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